Clinical Trial: Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence

U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960824) titled 'Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence' on April 29.

Brief Summary: The purpose of this study is to assess the clinical efficacy of the LCPT En-varsus [Life-Cycle Pharma Tacrolimus] initiated in de novo (Day 0 of transplantation) using the Biopsy Proven Acute Re-jection and iBox (full and abbreviated algo-rithms).

Study Start Date: May, 2025

Study Type: OBSERVATIONAL

Condition: Chronic Renal Disease

Intervention: DRUG: Life-Cycle Pharma Tacrolimus

Patients receiving LCPT Envarsus(R) [Life-Cycle Pharma Tacrolimus] within 24 hours of kidney transplanta...